$414 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 10.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BVS | BIOVENTUS | $170,563,000 | -2.7% | 12,096,702 | 0.0% | 41.24% | +4.6% | |
MDXG | Buy | MIMEDX GROUP, INC. | $110,287,000 | -21.9% | 23,415,584 | +0.2% | 26.66% | -16.0% |
EYPT | EYEPOINT PHARMACEUTICALS INC | $50,920,000 | -0.7% | 4,190,921 | 0.0% | 12.31% | +6.7% | |
TELA | Buy | TELA BIO, INC. | $38,568,000 | +58.1% | 3,316,236 | +74.0% | 9.32% | +69.9% |
VERO | VENUS CONCEPT, INC. | $23,363,000 | -15.9% | 21,169,457 | 0.0% | 5.65% | -9.6% | |
RVNC | REVANCE THERAPEUTICS INC | $8,913,000 | +19.5% | 457,085 | 0.0% | 2.16% | +28.4% | |
SONENDO INC | $7,990,000 | -30.4% | 1,992,526 | 0.0% | 1.93% | -25.1% | ||
MNOV | MEDICINOVA INC | $2,953,000 | -0.4% | 1,105,941 | 0.0% | 0.71% | +7.0% | |
CBIO | CATALYST BIOSCIENCES INC | $52,000 | -27.8% | 78,622 | 0.0% | 0.01% | -18.8% | |
AXGN | Exit | AXOGEN INC | $0 | – | -296,416 | -100.0% | -0.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
AXOGEN INC | 26 | Q4 2021 | 43.3% |
ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
ABIOMED INC | 20 | Q1 2018 | 52.1% |
CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.